Filter by Year: ALL 2022 2021 2020 2019 2018 2017 2015 Source FIERCE BIOTECH Merck teams up with cancer startup Foghorn in $425M deal July 8, 2020 Source ENDPOINTS NEWS Merck dangles up to $425 million to team with Flagship’s Foghorn Therapeutics on drugging the shape of DNA July 8, 2020 Source BIOSPACE Foghorn and Merck Ink Strategic Collaboration in Cancer for $425 Million+ July 8, 2020 Source XCONOMY Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck July 8, 2020 Source BIOTECH 2050 Podcast Ep. 9 – Carl P. Decicco, PhD, Chief Scientific Officer, Foghorn Therapeutics January 23, 2020
